Zentalis Pharmaceuticals's market cap is currently $176.03M. The company's EPS TTM is $-2.526; its P/E ratio is ―; Zentalis Pharmaceuticals is scheduled to report earnings on February 26, 2025, and the estimated EPS forecast is $-0.69. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ -1.39M	$ -1.43M	$ -544.00K	$ -160.00K	$ -111.00K
Operating Income	$ -248.99M	$ -227.29M	$ -216.54M	$ -118.79M	$ -46.84M
EBITDA	$ -275.50M	$ -219.87M	$ -164.01M	$ -117.94M	$ -46.73M
Net Income	$ -292.19M	$ -220.83M	$ -164.26M	$ -118.55M	$ -46.38M
Balance Sheet
Cash & Short-Term Investments	$ 482.92M	$ 437.37M	$ 339.89M	$ 338.50M	$ 82.42M
Total Assets	$ 551.69M	$ 539.31M	$ 454.51M	$ 365.56M	$ 102.66M
Total Debt	$ 43.15M	$ 45.17M	$ 45.91M	$ 2.00M	$ 781.00K
Net Debt	$ 15.11M	$ 2.10M	$ -13.80M	$ -52.95M	$ -81.64M
Total Liabilities	$ 114.30M	$ 105.29M	$ 90.03M	$ 32.18M	$ 19.06M
Stockholders' Equity	$ 437.28M	$ 434.02M	$ 364.48M	$ 333.38M	$ 76.78M
Cash Flow
Free Cash Flow	$ -208.41M	$ -166.30M	$ -160.20M	$ -87.58M	$ -39.49M
Operating Cash Flow	$ -207.82M	$ -163.75M	$ -154.09M	$ -86.83M	$ -39.14M
Investing Cash Flow	$ -44.46M	$ -114.18M	$ -18.11M	$ -284.83M	$ -352.00K
Financing Cash Flow	$ 237.30M	$ 261.04M	$ 178.52M	$ 360.44M	$ 81.83M

Currency in USD

Zentalis Pharmaceuticals Earnings and Revenue History

Income Statement >

Zentalis Pharmaceuticals Debt to Assets

Balance Sheet >

Zentalis Pharmaceuticals Cash Flow

Cash Flow >

Zentalis Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing